Significant fibrosis, as measured by FibroScan, was independently linked to type 2 diabetes in patients with metabolic dysfunction-associated steatotic liver disease.
After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a recent study shows.
A prospective evaluation by 16 diabetes specialists in Spain suggests that advanced hybrid closed-loop systems improve glycemic control in patients with type 1 diabetes.
New findings challenge the growing popularity of food-as-medicine programs by showing that one such program didn't improve glycemic control in individuals with high blood sugar.